Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Logo
Logo Abbott Laboratories
Business Summary
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:
- medicine (58%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;
- nutrition products (16.2%): pediatric nutrition products, nutritional supplements, and dietetic products;
- diagnostic systems and instruments (10.8%);
- vascular devices (7.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.;
- other (7.3%).
Net sales are distributed geographically as follows: the United States (42.1%), Japan (6.1%), the Netherlands (4.7%), Germany (4.4%), Canada (3.1%), France (2.9%), Italy (2.8%), the United Kingdom (2.6%), Spain (2.4%) and other (28.9 %).
Surperformance© rating of Abbott Laboratories
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals - Diversified
CountryTrading RatingInvestor Rating
JOHNSON & JOHNSONUSA
ROCHE HOLDING LTD.Switzerland
PFIZER INC.USA
NOVARTIS AGSwitzerland
MERCK & CO., INC.USA
SANOFIFrance
GLAXOSMITHKLINE PLCUnited Kingdom
BAYER AGGermany
BRISTOL MYERS SQUIBB CO.USA
NOVO NORDISK A/SDenmark
ELI LILLY & CO.USA
ABBOTT LABORATORIESUSA
TEVA PHARMACEUTICAL INDUSTRIES LIMITEDISRAEL
SHIRE PLCUnited Kingdom
ALEXION PHARMACEUTICALS, INC.USA
ACTAVIS INCUSA
MYLAN INC.USA
DAIICHI SANKYO COMPANY, LIMITEDJapan
CHUGAI PHARMACEUTICAL CO., LTD.Japan
UCBBelgium
BIOMARIN PHARMACEUTICAL INC.USA
TASLY PHARMACEUTICAL GROUP CO LTDCHINA
TAISHO PHARMACEUTICAL HOLDINGS CO LTDJapan
WARNER CHILCOTT PLCUSA
HISAMITSU PHARMACEUTICAL CO., INC.Japan
Sector Pharmaceuticals - Diversified
Data source :
© 2013 Thomson Reuters
Ratings :
© 2013 Surperformance
Shareholders
- BlackRock 5,32%
Advertisement
Managers
- Chairman and Chief Executive Officer :
    Miles D. White
- Chief Financial Officer :
    Thomas C. Freyman
- General Secretary :
    Laura J. Schumacher
Company contact information
100 road Abbott Park
60064-6400 Illinois
USA

Phone : +1 (847)937 6100
Fax : +1
Internet : http://www.abbott.com
Markets and indexes
- NYSE Euronext
- Main Market
- SP100 / SP500
Stock Exchange Codes
- ISIN Code :  US0028241000
- Bloomberg Code :  ABT:US
- Reuters Code :  ABT.N
- Datastream Code :  
Financial data source :
© 2013 Cofisem
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.